This initiative offers an integrated platform for accelerated drug discovery by combining cutting-edge technologies such as artificial intelligence (AI), high-throughput screening, medicinal chemistry, structural biology, and bioinformatics. The platform enables rapid hit identification, lead optimization, and candidate selection in a time-efficient manner.